-
1.USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF SMOOTH MUSCLE DISORDERS 审中-公开
标题翻译: 使用可溶性环氧化物水解酶抑制剂治疗轻度肌肉疾病公开(公告)号:US20090270452A1
公开(公告)日:2009-10-29
申请号:US12426154
申请日:2009-04-17
申请人: Heather K. Webb Hsu , Yi-Xin Wang , Le-Ning Zhang
发明人: Heather K. Webb Hsu , Yi-Xin Wang , Le-Ning Zhang
IPC分类号: A61K31/4545 , A61K31/4468 , A61K31/17 , A61P21/00
CPC分类号: A61K31/00 , A61K31/17 , A61K31/192 , A61K31/20 , A61K31/4468 , A61K31/4545 , A61K31/455 , A61K31/557
摘要: Disclosed herein are compounds, compositions, and methods for enhancing smooth muscle function in a subject by administration of soluble epoxide hydrolase inhibitors and for treating subjects with smooth muscle disorders including erectile dysfunction, overactive bladder, uterine contractions and irritable bowel syndrome.
摘要翻译: 本文公开了通过施用可溶性环氧化物水解酶抑制剂和用于治疗包括勃起功能障碍,膀胱过度活动症,子宫收缩和肠易激综合征的平滑肌疾病的受试者来增强受试者的平滑肌功能的化合物,组合物和方法。
-
2.USE OF SOLUBLE EPOXIDE HYDROLASE INHIBITORS IN THE TREATMENT OF INFLAMMATORY VASCULAR DISEASES 审中-公开
标题翻译: 可溶性环氧化物水解酶抑制剂在治疗炎症性血管疾病中的应用公开(公告)号:US20100063583A1
公开(公告)日:2010-03-11
申请号:US12541778
申请日:2009-08-14
申请人: Yi-Xin Wang , Le-Ning Zhang , Gabor M. Rubanyi
发明人: Yi-Xin Wang , Le-Ning Zhang , Gabor M. Rubanyi
IPC分类号: A61F2/82 , A61P29/00 , A61K31/4468 , A61K31/5375 , A61K31/4545 , A61K31/17
CPC分类号: A61K31/17 , A61K31/18 , A61K31/445 , A61K31/4523 , A61K31/5375
摘要: Disclosed herein are compositions and methods for treating inflammatory vascular diseases. Examples of inflammatory vascular disease include, but are not limited to, in-stent stenosis, coronary arterial diseases (CAD), angina, acute myocardial infarction, acute coronary syndrome, chronic heart failure (CHF), peripheral arterial occlusive diseases (PAOD), critical limb ischemia (CLI), cardiac, kidney, liver and intestinal ischemia, renal failure, cardiac hypertrophy, atherosclerosis, abdominal aortic aneurysm, vasculitis, carotid artery stenosis.
摘要翻译: 本文公开了治疗炎性血管疾病的组合物和方法。 炎性血管疾病的实例包括但不限于支架内狭窄,冠状动脉疾病(CAD),心绞痛,急性心肌梗死,急性冠状动脉综合征,慢性心力衰竭(CHF),外周动脉闭塞性疾病(PAOD), 严重肢体缺血(CLI),心脏,肾脏,肝脏和肠道缺血,肾衰竭,心脏肥大,动脉粥样硬化,腹主动脉瘤,血管炎,颈动脉狭窄。
-
3.SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS 审中-公开
标题翻译: 用于治疗代谢综合征和相关疾病的可溶性环氧化物水解酶抑制剂公开(公告)号:US20090197916A1
公开(公告)日:2009-08-06
申请号:US12264816
申请日:2008-11-04
IPC分类号: A61K31/44
CPC分类号: A61K31/17 , A61K31/445 , A61K31/4468 , A61K31/4545 , A61K31/5375 , A61K31/5377 , A61K31/5383
摘要: Compounds, compositions, and methods for inhibiting the onset of metabolic syndrome and treating related disorders in a subject in need of such therapy are disclosed.
摘要翻译: 公开了用于抑制需要这种治疗的受试者中代谢综合征发作和治疗相关疾病的化合物,组合物和方法。
-
-